Clinical Trial

Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen

Name: Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen — clinical trial record (NCT05512754)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the impact of ibuprofen in men with elevated serum PSA.

Protocol Amendment History 8 amendments

This ClinicalTrials.gov record has been amended 8 times since 2022-08-21; most recent amendment 2025-12-02.

Status change: Active, Not Recruiting → Recruiting 2022-10-10

Trial Details

NCT Number	NCT05512754
Lead Sponsor	University of Chicago
Conditions	Elevated Serum PSA
Enrollment	200 participants
Start Date	2022-08-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-12-09